Science Exchange to offer genetically engineered rodent models with new partnership

By Maggie Lynch

- Last updated on GMT


Related tags Science exchange CRISPR Gene editing

Science Exchange has partnered with Taconic Biosciences, a supplier of genetically engineered rodent models to offer access to Taconic’s portfolio including the company’s Easi-CRISPR technology.

The partnership between Taconic and Science Exchange will offer Taconic’s rodent model design and breeding services to Science Exchange users.

Kelly Grover, director of marketing communications at Taconic, told us, “Sourcing of the key products and services needed for biomedical research is a critical step in the drug discovery process.  Participating in a system like that created by Science Exchange serves to connect researchers with partners like Taconic to facilitate that critical step.”

According to Grover, Taconic’s rodent models and services are used in a variety of research projects from basic, transitional, and drug discovery. “Our market includes academic, non-profit, government, and commercial organizations all over the world and of all sizes,”​ said Grover.

Taconic has gene-editing technologies – including homologous recombination, pronuclear injection, shRNAi, CRISPR, and Easi-CRISPR – to its model generation services. According to the company, the use of a variety of tools in its model generation allows for each client’s needs to be met.

The addition of Easi-CRISPR technology to the company’s gene-modifying toolkit supports insertion of large segments of exogenous DNA which can generate knock-in mice for some applications, and is more efficient than CRISPR, according to the company.

Taconic added Easi-CRISPR to its toolkit upon the acquisition of a non-exclusive license from the University of Nebraska.

Science Exchange has entered into multiple partnerships including Agilent​, LabCentral,​ AUM Biotech​ and the CRO Bioanalytics​. 

Related topics Preclinical Research Preclinical

Related news

Show more

Related products

show more

PBPK modeling that saves you time and money

PBPK modeling that saves you time and money

Content provided by Lonza Small Molecules | 09-Oct-2023 | White Paper

Understanding pharmacokinetic behaviors ahead of later-stage development means making informed decisions earlier. This enhanced capability helps your drug...

Related suppliers

Follow us